Heart Transplant Rejection Global Clinical Trials Review, H2, 2017

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 118

Heart Transplant Rejection Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H2, 2017” provides an overview of Heart Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Heart Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Zavante Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a developer of novel therapies for the treatment of infectious diseases. The company offers drugs for the treatment of diseases that affect patients in the hospital setting. Its lead product candidate ZOLYD, is an investigational first-in-class injectable epoxide antibiotic. Zavante's ZOLYD is being developed for the treatment of infectious diseases such as complicated urinary tract infections, acute bacterial skin and skin structure infections, and others. The company works in collaboration with private and public firms to conduct its research and development activities. Zavante is headquartered in San Diego, California, the US. Zavante Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances......
$250

Tenet Healthcare Corp (THC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Tenet Healthcare Corp (Tenet) is a health care services company that operates hospitals, diagnostic imaging centers, ambulatory surgery centers, and related health care facilities along with its subsidiaries and affiliates. It is one of the leading healthcare services companies in the US, with a comprehensive healthcare delivery network. The company serves urban and rural communities in US through general hospitals, including children's hospitals, specialty hospitals, academic medical centers and critical access hospitals. Tenet's subsidiaries provide healthcare services through several free-standing and provider-based diagnostic imaging centers, free-standing emergency department, urgent care centers and ambulatory surgery centers. It also operates private hospitals and clinics......
$250

PsiOxus Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transforming agent. It also has an antibody armed oncolytic platform under development. PsiOxus's products find application in the treatment of various cancer diseases such as cachexia, sarcopenia, metastatic cancer, and solid tumours, among others. It holds expertise in enhancing the therapeutic potency, safety and delivery kinetics through genetic modification to produce cancer vaccines. PsiOxus is headquartered in Abingdon, the UK. PsiOxus Therapeutics Ltd - Pharmaceuticals & Healthcare - Dea......
$250

Mission Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mission Therapeutics Ltd (Mission) is a drug discovery company that develops small molecule drugs targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company's USP30 is the DUB that localizes to the outer mitochondrial membrane. Its USP7 is a DUB with oncology links and an anti-cancer target. Mission's DUB programmes also include a number of other DUB targets in oncology such as DNA damage response and synthetic lethal mechanisms, neurodegeneration and inflammation. The company receives grants to support the discovery and preclinical development of inhibitors directed against a specific DUB. Mission is headquartered in Cambridge, the UK. Mission Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you......
$250

Ignyta Inc (RXDX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnostic (Dx) technology platform. Its clinical pipeline includes selective tyrosine kinase inhibitor of the TrkA, TrkB, TrkC, ROS1 and ALK protein and a small molecule inhibitor of BRAF, EGFR and RET. Ignyta's other pipeline products comprise taladegib, a small molecule smoothened antagonist; RXDX-105, a small molecule multikinase inhibitor; and RXDX-106, a small molecule, pseudo-irreversible inhibitor of TYRO3, AXL and Mer. The company also develops trailblaze diagnostic programs. Ignytais headqu......
$250

Invectys SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company's product pipeline includes INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine (UCPVax), a human telomerase peptide-based vaccine; INMAB-1, a monoclonal antibody; and TelVet, a dog telomerase DNA-based anti-cancer vaccine and similar to INVAC-1. Its TelVet is developed for the treatment of pet cancers such as dog cancers. The company's technology restores and mobilizes the anti-tumor ability of the immune system of cancer patients. Invectys is headquartered in Paris, France. Invectys SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M......
$250

Obagi Medical Products Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Obagi Medical Products Inc (Obagi), a subsidiary of Valeant Pharmaceuticals International Inc is a drug company that manufactures, sells, and markets skin care systems. The company provides products that include targeted solutions, tretinoin products, transformation systems, skin recovery, in-office procedures, essential products, and others. It also offers obagi professional-c serums, obagi condition and enhance systems, obagi nu-derm system, obagi blue peel, obagi blue peel radiance, and obagi rosaclear system, obagi elastiderm eye products, and others. The company's products are used for treating fine lines, wrinkles, acne, melasma, laxity, skin shallowness, photo damage, hyper pigmentation, and others. Obagi is headquartered in Irvine, California, the US. Obagi Medical Pr......
$250

NuGEN Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA and RNA, target capture, ChIP-Seq, and Methyl-Seq, Microarrays and qPCR, and bioinformatics and automation software solutions. NuGen's next generation technologies are used in the areas of cancer detection, infectious disease, liquid biopsy, agrigenomics, microbiomics and epigenetics. The company markets its products through a network of distributors located across the US, Australia, the Netherlands, South Korea, Canada, China, Spain, Hong Kong, among others. It operates in San Carlos, the US......
$250

Kuros Biosciences Ltd (KURN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kuros Biosciences Ltd (Kuros Biosciences) is a biotechnology company that develops products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products includes MagnetOs Granules, MagnetOs Putty, KUR-111, KUR-113 and KUR-112. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company's lead sealant product is Neuroseal (KUR-023) developed as an adjunct to suturing for sealing of the dura after cranial surgery. Kuros Biosciences is headquartered in Schlieren, Switzerland. Kuros Bioscienc......
$250

Pharm-Olam International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics submissions, data management, biostatistics, pharmacovigilance, rescue studies, project management, import and export licenses, contract negotiation and administration and product registration among others. Pharm-Olam's target therapeutic areas include anti-infectives, cardiology, dermatology, endocrinology, gastroenterology, oncology, respiratory, rheumatology, and others. The company has operations across North America, Western Europe, Central and Eastern Europe, Latin America, Asia and South A......
$250